Genetics of colorectal cancer

Seminars in Surgical Oncology

Volumn 15, Issue 2, 1998, Pages 126-130

  Kennedy, Eugene P ^a   Hamilton, Stanley R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoma; Adenomatous polyposis coli; APC genes; Carcinoma; Chromosome deletion; Colorectal neoplasms genetics; DCC genes; DNA methylation; DNA repair; DNA replication; Hereditary nonpolyposis colorectal cancer; Incidence; Mutation; p53 genes; Ras genes; Tumor suppressor genes

Indexed keywords

ADENOMATOUS POLYP; CANCER GENETICS; CANCER STAGING; COLORECTAL CANCER; DNA METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR SUPPRESSOR GENE;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DISEASE PROGRESSION; DNA METHYLATION; GENES, TUMOR SUPPRESSOR; HUMANS;

EID: 0031841412     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199809)15:2<126::AID-SSU10>3.0.CO;2-0     Document Type: Review

References (54)

1. Sugarbaker JP, Gunderson LL, Wittes RE: Colorectal cancer. In DeVita VT, Hellman S, Rosenberg SA (eds): "Cancer: Principles and practices of oncology." 2nd ed. Philadelphia: JB Lippincott; 1985. p. 800-803.
2. Houlston RS, Collins A, Slack J, Morton NE: Dominant genes for colorectal cancer are not rare. Ann Hum Genet 1992,56(Pt 2):99-103.
3. Stern HS, Smith A: Recognition, screening, and medical management of familial adenomatous polyposis. Semin Colon Rectal Surg 1995;6:19-24.
4. Jagelman DG: Extracolonic manifestations of familial polyposis coli. Cancer Genet Cytogenet 1987;27:319-325.
5. Berk T, Cohen Z, McLeod R, Stern HS: Management of mesenteric desmoid tumors in familial adenomatous polyposis. Can J Surg 1992;35.393-395.
6. Bodmer WF, Bailey CJ, Bodmer J, et al: Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328(6131):614-616.
7. Leppert M, Dobbs M, Scambler P, et al: The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987;238(4832):1411-1413.
8. Kinzler KW, Nilbert MC, Su LK, et al: Identification of FAP locus genes from chromosome 5q21. Science 1991;253(5020):661-665.
9. Groden J, Thliveris A, Samowitz W, et al: Identification and characterization of the familial polyposis coli gene. Cell 1991;66.589-600.
10. Smith KJ, Johnson KA, Bryan TM, et al: The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 1993;190:2846-2850.
11. Joslyn G, Richardson DS, White R, Albert T: Dimer formation by an N-terminal coiled coil in the APC protein. Proc Natl Acad Sci USA 1993;90:11109-11113.
12. Su LK, Johnson KA, Smith KJ, et al: Association between wild type and mutant APC gene products. Cancer Res 1993;53:2728-2731.
13. Rubinfeld B, Souza B, Albert I, et al: Association of the APC gene product with beta-catenin. Science 1993;262(5140):1731-1734.
14. Su LK, Vogelstein B, Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 1993;262(5140):1734-1737.
15. Smith KJ, Levy DB, Maupin P, et al: Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res 1994;54:3672-3675.
16. Munemitsu S, Souza B, Muller O, et al: The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 1994;54:3676-3681.
17. Powell SM, Zilz N, Beazer-Barclay Y, et al: APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359(6392):235-237.
18. Warthin AS: Heredity with reference to carcinoma. Arch Intern Med 1913;12:546-555.
19. Lynch HT, Kimberling W, Albano WA, et al: Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer 1985;56:934-938.
20. Vasen HF, Mecklin JP, Khan PM, Lynch HT: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-425.
21. Mecklin JP: Frequency of hereditary colorectal carcinoma. Gastroenterology 1987;93:1021-1025.
22. Aaltonen LA, Sankila R, Mecklin JP, et al: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prevent 1994;18:57-63.
23. Ponz de Leon M, Sassatelli R, Benatti P, Roncucci L: Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population based on registry. Cancer 1993;71:3493-3501.
24. Westlake PJ, Bryant HE, Huchcroft SA, Sutherland LR: Frequency of hereditary nonpolyposis colorectal cancer in Southern Alberta. Dig Dis Sci 1991;36:1441-1447
25. de la Chapelle A, Peltomaki P: Genetics of hereditary colon cancer [Review]. Annu Rev Genet 1995;29:329-348.
26. Fischel R, Lescoe MK, Rao MR, et al: The human mutator gene homologue MSH2 and its association with hereditary nonpolyposis colon cancer [published erratum appears in Cell 1994;77:167]. Cell 1993;75:1027-1038.
27. Leach FS, Nicolaides NC, Papadopoulos N, et al: Mutations of a mutS homologue in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-1225.
28. Bronner CE, Baker SM, Morrison PT, et al: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 1994; 368(6468):258-261.
29. Nicolaides NC, Papadopoulos N, Liu B, et al: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371(6492):75-80.
30. Liu B, Parsons RE, Hamilton SR, et al: hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 1994;54:4590-4594.
31. Han HJ, Maruyama M, Baba S, et al: Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary nonpolyposis colorectal cancer (HNPCC). Hum Mol Genet 1995;4:237-242.
32. Aaltonen LA, Peltomaki P, Leach FS, et al: Clues to the pathogenesis of familial colorectal cancer. Science 1993;260(5109): 812-815.
33. Loeb LA: Microsatellite instability: marker of a mutator phenotype in cancer [Review]. Cancer Res 1994;54:5059-5063.
34. Lazar V, Grandjouan S, Bognel C, et al: Accumulation of multiple mutations in tumor suppressor genes during colorectal tumorigenesis in HNPCC patients. Hum Mol Genet 1994;3:2257-2260.
35. Parsons R, Li GM, Longley MJ, et al: Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993;75:1227-1236.
36. Knudson AG Jr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823.
37. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
38. Fearon ER, Hamilton SR, Vogelstein B: Clonal analysis of human colorectal tumors. Science 1987;238(4824):193-197.
39. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-532.
40. Kinzler KW, Nilbert MC, Vogelstein B, et al: Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991;251(4999):1366-1370.
41. Lechleiter J, Hellmiss R, Duerson K, et al: Distinct sequence elements control the specificity of G protein activation by muscarinic acetylcholine receptor subtypes. EMBO J 1990;9:4381-4390.
42. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene [Review]. Nature 1991;351(6326):453-456.
43. Baker JB, Preisinger AC, Jessup JM, et al: p 53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-7722.
44. Fearon ER, Cho KR, Nigro JM, et al: Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990;247(4938):49-56.
45. Miyaki M, Seki M, Okamoto M, et al: Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 1990;50:7166-7173.
46. Zetter BR. Adhesion molecules in tumor metastasis [Review]. Semin Cancer Biol 1993;4:219-229.
47. Barbacid M: ras genes [Review]. Annu Rev Biochem 1987;56: 779-827.
48. Ichii S, Takeda S, Horii A: Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene 1993;8:2399-2405.
49. Goyette MC, Cho K, Fasching CL, et al: Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol 1992;12:1387-1395.
50. Knudson AG Jr: Hereditary cancer, oncogenes, and anti-oncogenes. Cancer Res 1985;45:1437-1443.
51. Herskowitz I: Functional inactivation of genes by dominant negative mutations [Review]. Nature 1987;329(6136):219-222.
52. Kraiss S, Quaiser A, Oren M, Montenarh M: Oligomizeration of oncoprotein p53. J Virol 1988;62:4737-4744.
53. Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP: Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985,228(4696):187-190.
54. Schmid M, Haaf T, Grunert D: 5-Azacytidine-induced undercondensations in human chromosomes. Hum Genet 1984; 67.257-263.